Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761(®)

BACKGROUND: The Ginkgo biloba special extract, EGb 761(®) has been widely used in the treatment of neuropsychiatric disorders, including Alzheimer’s disease (AD). METHODS: To guide clinical practice in the Asian region, the Asian Clinical Expert Group on Neurocognitive Disorders compiled evidence‐ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Kandiah, Nagaendran, Ong, Paulus Anam, Yuda, Turana, Ng, Li‐Ling, Mamun, Kaysar, Merchant, Reshma Aziz, Chen, Christopher, Dominguez, Jacqueline, Marasigan, Simeon, Ampil, Encarnita, Nguyen, Van Thong, Yusoff, Suraya, Chan, Yee Fai, Yong, Fee Mann, Krairit, Orapitchaya, Suthisisang, Chuthamanee, Senanarong, Vorapun, Ji, Yong, Thukral, Ramesh, Ihl, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488894/
https://www.ncbi.nlm.nih.gov/pubmed/30648358
http://dx.doi.org/10.1111/cns.13095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488894/
https://www.ncbi.nlm.nih.gov/pubmed/30648358
http://dx.doi.org/10.1111/cns.13095

Ejemplares similares